Position in NAMS
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$305
-$45 QoQ
Shares Held
9
-10.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#195
of 198 holders
Holding Since
Mar 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GAMMA Investing LLC holds $18,803,269 across 254 Biotechnology names. NAMS ranks #241 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,918 | $3,436,378 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,067 | $1,288,857 | |
| 3 | MRNA |
Moderna, Inc.
|
14,479 | $1,013,964 | |
| 4 | INCY |
Incyte Corp
|
8,213 | $931,025 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,769 | $619,529 | |
| 6 | EXEL |
Exelixis, Inc.
|
11,025 | $599,870 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
14,637 | $518,003 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
4,640 | $403,448 |
All Filings in NAMS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $305 | 9 | Shares | Defined | 2026-07-07 | |
| 2025-12-31 | $350 | 10 | Shares | Defined | 2026-01-05 | |
| 2025-03-31 | $143 | 7 | Shares | Defined | 2025-04-15 | |
| No filing history on record for this holder in this stock. | ||||||